Vicore Pharma Holding AB
STO:VICO

Watchlist Manager
Vicore Pharma Holding AB Logo
Vicore Pharma Holding AB
STO:VICO
Watchlist
Price: 10 SEK -0.4% Market Closed
Market Cap: 2.8B SEK

Net Margin
Vicore Pharma Holding AB

-4 992.9%
Current
-1 210%
Average
-6.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-4 992.9%
=
Net Income
-424.4m
/
Revenue
8.5m

Net Margin Across Competitors

No Stocks Found

Vicore Pharma Holding AB
Glance View

Market Cap
2.8B SEK
Industry
Biotechnology

Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. The company is headquartered in Goeteborg, Vastra Gotalands. The company went IPO on 2015-12-10. The firm's portfolio contains small molecules with potential indications, including anti-inflammation, nerve generation and cardiovascular disease. The firm is a wholly owned subsidiary of Mintage Scientific AB.

VICO Intrinsic Value
1.96 SEK
Overvaluation 80%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-4 992.9%
=
Net Income
-424.4m
/
Revenue
8.5m
What is the Net Margin of Vicore Pharma Holding AB?

Based on Vicore Pharma Holding AB's most recent financial statements, the company has Net Margin of -4 992.9%.

Back to Top